Finze Ronja, Laubach Markus, Russo Serafini Mairim, Kneser Ulrich, Medeiros Savi Flavia
Centre for Biomedical Technologies, School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Department of Hand-, Plastic and Reconstructive Surgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, 67071 Ludwigshafen, Germany.
Biomedicines. 2023 Oct 13;11(10):2781. doi: 10.3390/biomedicines11102781.
Large-volume bone defect regeneration is complex and demands time to complete. Several regeneration phases with unique characteristics, including immune responses, follow, overlap, and interdepend on each other and, if successful, lead to the regeneration of the organ bone's form and function. However, during traumatic, infectious, or neoplastic clinical cases, the intrinsic bone regeneration capacity may exceed, and surgical intervention is indicated. Scaffold-guided bone regeneration (SGBR) has recently shown efficacy in preclinical and clinical studies. To investigate different SGBR strategies over periods of up to three years, we have established a well-characterized ovine large segmental tibial bone defect model, for which we have developed and optimized immunohistochemistry (IHC) protocols. We present an overview of the immunohistochemical characterization of different experimental groups, in which all ovine segmental defects were treated with a bone grafting technique combined with an additively manufactured medical-grade polycaprolactone/tricalcium phosphate (mPCL-TCP) scaffold. The qualitative dataset was based on osteoimmunological findings gained from IHC analyses of over 350 sheep surgeries over the past two decades. Our systematic and standardized IHC protocols enabled us to gain further insight into the complex and long-drawn-out bone regeneration processes, which ultimately proved to be a critical element for successful translational research.
大体积骨缺损的再生过程复杂,需要时间来完成。几个具有独特特征的再生阶段,包括免疫反应,相继出现、相互重叠且相互依存,若成功,则会导致器官骨的形态和功能得以再生。然而,在创伤性、感染性或肿瘤性临床病例中,内在的骨再生能力可能不足,此时就需要进行手术干预。支架引导骨再生(SGBR)最近在临床前和临床研究中显示出了疗效。为了在长达三年的时间里研究不同的SGBR策略,我们建立了一个特征明确的绵羊大段胫骨骨缺损模型,并为此开发和优化了免疫组织化学(IHC)方案。我们概述了不同实验组的免疫组织化学特征,其中所有绵羊节段性缺损均采用骨移植技术结合增材制造的医用级聚己内酯/磷酸三钙(mPCL-TCP)支架进行治疗。定性数据集基于过去二十年对350多例绵羊手术进行免疫组织化学分析获得的骨免疫学研究结果。我们系统且标准化的免疫组织化学方案使我们能够进一步深入了解复杂且漫长的骨再生过程,这最终被证明是成功进行转化研究的关键要素。